Saturday - November 22, 2025

Category Archives: Science

Non Small Cell Lung Cancer Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed

DelveInsight’s “NSCLC Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the NSCLC pipeline landscape. It covers the NSCLC pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NSCLC pipeline … Continue reading →

Retinal Vein Occlusion Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed

DelveInsight’s “Retinal Vein Occlusion Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape. It covers the Retinal Vein Occlusion pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Alport Syndrome Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed

DelveInsight’s “Alport Syndrome Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in the Alport Syndrome pipeline landscape. It covers the Alport Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Fibrodysplasia Ossificans Progressiva Pipeline Outlook Report 2025: MOA, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed

DelveInsight’s “Fibrodysplasia Ossificans Progressiva Pipeline Insight 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in the Fibrodysplasia Ossificans Progressiva pipeline landscape. It covers the Fibrodysplasia Ossificans Progressiva pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Chondrosarcoma Pipeline Outlook Report 2025: MOA, Companies, Companies, Clinical Trials, Expanding Therapeutic Classes, and Future Market Impact Revealed

DelveInsight’s “Chondrosarcoma Pipeline Insight 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Chondrosarcoma pipeline landscape. It covers the Chondrosarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chondrosarcoma pipeline … Continue reading →

Extensive Global Research Continues to Highlight the Environmental, Public Health, and Animal Welfare Impacts of Factory Farming as Worldwide Interest in Plant-Based Diets Accelerates

Over the past two decades, extensive research from international scientific bodies, peer-reviewed journals, environmental agencies, and public health organizations has consistently documented the far-reaching impacts of industrial animal agriculture — commonly known as factory farming. These findings have contributed to … Continue reading →

Ibogaine By David Dardashti Celebrates 5-Year Milestone: Data Confirms Reflection Treatment Significantly Improves Long-Term Success Against Depression

HOLLYWOOD, FL – November 18, 2025 – Ibogaine By David Dardashti, a globally recognized leader in psychedelic-assisted therapies, today announced the five-year anniversary of the strategic integration of its specialized Ibogaine “reflection” treatment protocol. Following five years of meticulous data collection … Continue reading →

Messe.TV reports from Medica 2025: Developments, focus areas and key players in global healthcare and medical technology

Developments, focus areas and key players in global healthcare and medical technology at Medica 2025 Medica 2025 is one of the most influential international meeting points for professionals from healthcare, medical technology, clinical environments and research. Messe.TV accompanies the event … Continue reading →